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The Effect of Aging and Exogenous Testosterone Replacement on
Nitric Oxide Concentration and Activity of Nitric Oxide Synthase in the
Rat Corpus Cavernosum
Manabu Shiono
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The effects of testosterone replacement on the nitric oxide (NO) concentration and
activity of NO synthase (NOS) in the penis were investigated.  Male Wistar rats (n = 39)
were divided into 5 groups:  14-week-old males, 13-month-old males, 15-month-old
males, 15-month-old males treated with low-dose testosterone replacement and 15-
month-old males treated with high-dose testosterone replacement.  The testosterone
concentration in serum and the NO concentration in penile tissue were measured, and
the endothelial NOS (eNOS) and neuronal NOS (nNOS) expressions were examined
immunohistochemically.  The testosterone concentration in serum tended to decrease
with aging, but the 15-month-old testosterone-replaced rats maintained almost the same
level as the 14-week-old rats.  Nitrite and nitrite/nitrate concentrations in penile tissue
tended to decrease with aging.  Nitrite concentrations in the 15-month-old rats were
significantly higher in the testosterone-replaced groups than in the non-replaced group,
but no significant difference in nitrite/nitrate concentration was recognized between
the 15-month-old rats not treated and treated with testosterone replacement.  Immuno-
histochemical staining for eNOS and nNOS demonstrated a decreasing expression of
the 2 NOSs with aging and recovering of the NOSs by testosterone replacement.  The
results of this study suggest that NO plays a major role in the mediation of penile erection,
and testosterone replacement may favorably alter age-related erectile dysfunction.
Key words:  aging; immunohistochemical staining; nitric oxide; testosterone replacement
Abbreviations:  eNOS, endothelial NOS; iNOS, inducible NOS; mRNA, messenger RNA; nNOS, neuronal
NOS; NO, nitric oxide; NOS, NO synthase; PBS, phosphate-buffered saline
Recently, several studies have revealed that
nitric oxide (NO) is an important neural mes-
senger which mediates penile erection (Ignarro
et al., 1990; Holmquist et al., 1991; Kim et al.,
1991; Burnett et al., 1992; Rajifer et al., 1992).
Erection is mediated by the release of NO from
non-adrenergic non-cholinergic nerve termi-
nals, the endothelium of penile blood vessels,
and corporal smooth muscle, producing smooth
muscle relaxation and vasodilation (Burnett,
1997).  NO stimulates the formation of guany-
late cyclase in smooth muscle cells, converting
GTP to 3'5'-cyclic GMP (cGMP) (Burnett,
1997).  A cascade of cGMP-dependent intra-
cellular events then leads to a decrease in intra-
cellular calcium, ultimately causing smooth
muscle relaxation, in part through changes in
potassium conductance (Seftel et al., 1996;
Burnett, 1997).
The production of NO is mediated by a
family of NO synthase (NOS) that all represent
distinct gene products.  These enzymes produce
NO through a complex set of redox reactions
that result in the conversion of L-arginine to L-
citrulline.  The isoforms of NOS have been
categorized as being either inducible or consti-
tutive (Forstermann et al., 1995).  The inducible
isoform of NOS (iNOS) is associated primarily
with macrophages and is activated by specific
cytokines as part of the immune response.  The
endothelial (eNOS) and neuronal (nNOS) iso-
forms of NOS are constitutive and are activated,
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dose testosterone replacement group (G4, n = 8)
and high-dose testosterone replacement group
(G5, n = 8).  In the replacement groups, Silastic
tubes (Dow Corning, Midland, MI; outer diame-
ter, 3.17 mm; inner diameter, 1.57 mm) which
were 3 cm in length, and contained 40 mg of tes-
tosterone powder (Sigma, St. Louis, MO) were
subcutaneously implanted in the backs of the rats
when they were anesthetized with pentobarbital
(30 mg/kg) at the age of 13 months, and the
replacement was continued for 2 months.  In
G4, 4 tubes were implanted and in G5, 8 tubes
were implanted.  As each group reached the age
desired for the experiment as mentioned above,
blood (7–8 mL) was collected through the infer-
ior vena cava of each rat under pentobarbital
(30 mg/kg) anesthesia, and the serum was
separated by centrifugation and stored at –80˚C
until it was assayed.  Total testosterone and free
testosterone concentrations in serum were de-
termined by radioimmunoassay (Total Testos-
terone Kit and Free Testosterone Kit, DPC Corp.,
Tokyo, Japan).  Rats were killed in succession
by means of additional pentobarbital (30 mg/
kg), and the penis was removed and weighed.
The penis was divided into 2 pieces, and one
was used for measurement of NO concentration
and the other was used for immunohistochemis-
try.
Measurement of NO concentration in pen-
ile tissue
The final products of NO in vivo are nitrite and
nitrate.  The relative proportion of nitrite and
nitrate is variable and cannot be predicted with
certainty.  Thus, the best index of total NO pro-
duction is the sum of both nitrite and nitrate.
NO was measured by means of the Griess
method.  The penile tissue was weighed and
homogenized in phosphate-buffered saline
(PBS) (pH 7.4) and centrifuged at 10,000 × g
for 20 min.  The supernatant was ultracentrifug-
ed at 100,000 × g for 15 min, and then the super-
natant was ultrafiltered using a 30 kDa molecu-
lar weight cut-off filter.  The sample was assay-
ed by means of a nitrate/nitrite colorimetric as-
say kit (Cayman Chemical Co., Ann Arbor, MI).
The values were estimated per tissue weight and
in part, by an increased concentration of
intracellular calcium and calmodulin binding to
the enzyme.  Experimental evidence suggests
that the constitutive isoforms of NOS may be
responsible for NO production in penile erec-
tion (Bush et al., 1992; Burnett et al., 1993).
Recent evidence suggests that eNOS and its
subsequent production of NO may be a signifi-
cant route by which NO-mediated cavernosal
relaxation is brought about because transgenic
mice lacking nNOS are still capable of erectile
activity with pelvic nerve stimulation (Burnett
et al., 1996).
A decrease in the serum testosterone level
with aging may contribute to a reduction of sex-
ual potency (Meisel and Sachs, 1994; Garban et
al., 1995), although this reduction with aging is
a multi-factorial phenomenon.
A recent study also hypothesized that andro-
gens maintained and facilitated male sexual
potency through enhancement or maintenance
of NOS activity in the corpus cavernous tissue
in the penis (Mills et al., 1996).  In addition,
several studies have shown that androgen re-
placement facilitated neural activities in some
areas of the brain which mediate sexual func-
tion (Okamura et al., 1994a, 1994b; Pu et al.,
1996).
In this article, the changes in the serum tes
tosterone concentration, NO concentration and
NOS protein expression in penile tissue were
examined by using the rat as our model of ag-
ing, and the changes brought about by testos-
terone replacement, as well.  The goal in this
study was to evaluate whether  testosterone re-
placement helps to resolve age-related erectile
dysfunction.
Materials and Methods
Subjects used were 14-week-old (G1, n = 10),
13-month-old  (G2, n = 5) and 15-month-old
male Wistar rats (n = 24) (SLC, Shizuoka,
Japan).  All rats were housed in a room with
controlled lighting and allowed access to food
and water ad libitum.  The 15-month-old rats
were divided into 3 groups as follows:  no tes-
tosterone replacement group (G3, n = 8), low-
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per amount of protein in the tissue.  Protein was
determined using a commercial kit (BCA Protein
Assay Reagent Kit, Pierce, Rockford, IL).
eNOS and nNOS immunohistochemistry
in penile tissue
The penis was immediately fixed with neutral
buffered 15% formaldehyde-saline.  The tissues
were embedded in paraffin after the fixation.
Sections (3 µm) were subjected to immuno-
histochemical stains for eNOS and nNOS.  The
sections were retrieved by micro-wave and
treated with 3% methanol/hydrogen peroxide
for 15 min at room temperature to reduce back-
ground staining.  They were then reacted with
200 µg/mL of rabbit anti-eNOS or nNOS poly-
clonal antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) at a 1:5000 dilution in Dako
antibody diluent (Dako, Carpenteria, CA) over-
night at 4˚C.  Sections were washed with PBS
and the specifically bound first antibodies were
visualized by means of biotinylated anti-rabbit
secondary antibody and with a Vectastain ABC
kit (Vector Laboratories, Burlingame, CA) for 30
min at room temperature.  Again, sections were
washed with PBS and incubated for 30 min with
horseradish peroxidase-labeled streptavidin at
room temperature.  After the incubation period,
tissue sections were washed and a diaminoben-
zidine peroxidase substrate solution (Vector)
was applied for 5 min.  The reaction was stop-
ped by washing the sections in water.  Mayer’s
hematoxylin was used for counterstaining.
Statistical analysis
Experimental values were expressed as mean ±
SEM for the number of separate determinations
indicated in each case.  The non-parametric t-
test was used for calculating probabilities when
comparing 2 groups independent from the oth-
ers, and those with P values less than 5% (P <
0.05) were considered significant.
Results
Body weight and  penile weight
Among the group of 15-month-old rats, body
weight and penile weight of rats treated without
testosterone replacement (G3) were not sig-
nificantly different from those treated with
testosterone replacement groups (G4 and G5)
(Table 1).
Serum testosterone concentration
The total testosterone level tended to decrease
with aging, but the level in the 15-month-old
rats without testosterone replacement (G3) was
significantly lower than that in 14-week-old rats
(G1).  Among 15-month-old rats, the rats with
Table 1. Body and penile weight, and testosterone concentration in serum
Young adult rats Middle-aged rats
14-week-old 13-month-old     15-month-old
G1 G2 G3          Testosterone-replaced
[10] [5] [8] Low-dose High-dose
G4 G5
[8] [8]
Body weight (g) 367  ± 14 596  ± 59 562  ± 39* 554  ± 19 587  ± 47
Penis weight (mg) 394  ± 40 659  ± 73 596  ± 42* 621  ± 45 621  ± 38
Total testosterone (ng/mL)     2.0 ± 0.4     1.0 ± 0.2     0.8 ± 0.1*     3.7 ± 0.4**     5.0 ± 1.1**
Free testosterone (pg/mL)     8.3 ± 1.9     5.2 ± 0.8     4.2 ± 1.2*   14.5 ± 3.6**   20.0 ± 6.7**
Values represent mean ± SEM.
[  ], number of animals.
Significant difference (P < 0.05): *G3 versus G1; **G4 or G5 versus G3.
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low- and high-dose testosterone
replacement (G4 and G5) showed
significantly higher levels of total
testosterone than the rats without re-
placement (G3), but they did not
have significantly higher levels than
14-week-old rats (Table 1).  The free
testosterone level in 15-month-old
rats without testosterone replace-
ment was significantly lower than
that in 14-week-old rats.  Among 15-
month-old rats, the free testosterone
level in the low- and high-dose tes-
tosterone replacement groups was
significantly higher than that in the
non-replacement group (Table 1).
Table 2. Nitrite and nitrite/nitrate concentration in penile tissue
Young adult rats Middle-aged rats
14-week-old 13-month-old 15-month-old
G1 G2 G3            Testosterone-replaced
[10] [5] [8] Low-dose High-dose
G4 G5
[8] [8]
Nitrite† (µmol/g wt) 17.3   ± 3.4 16.2   ± 3.4 11.0   ± 1.9 31.5   ± 3.6* 27.0   ± 6.6*
Nitrite‡ (nmol/mg pro)   1.11 ± 0.24   1.05 ± 0.22   0.54 ± 0.05   2.59 ± 0.73*   1.61 ± 0.50*
Nitrite/nitrate† (µmol/g wt) 48.4   ± 7.1 42.1   ± 5.2 40.6   ± 4.3 43.4   ± 6.7 49.8 ± 10.4
Nitrite/nitrate‡(nmol/mg pro)   3.28 ± 0.53   2.47 ± 0.33   2.32 ± 0.23   3.27 ± 0.54   3.10 ± 0.66
†Per tissue weight (µmol/g weight).
‡Per amount of protein in the tissue (nmol/mg protein).
Values represent mean ± SEM.
[  ], number of animals.
pro, protein; wt, weight.
Significant difference (P < 0.05): *G4 or G5 versus G3.
Fig. 1.  Sections of rat corpus cavernosum tissue immunostained by ant-endothelial nitric oxide synthase
(eNOS) antibodies (original magnification × 200).  Sections are counterstained with hematoxylin.
A: Immunohistochemical localization of eNOS shows strong staining of the vascular endothelium.
C: Aged rats without replacement have weak staining.
D and E: Testosterone replacement restored the same level of staining as in the young adult group.
[Figs. 1A and B on p. 48 and Figs. 1C–E on p. 49]
A
B
A: G1, young adult rat (14-week-old)
B: G2, middle-aged rat (13-month-old)
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Figs. 1C–E.  Continued from the previous page.
Nitrite and nitrite/nitrate concentration in penile tissue
Nitrite level
This level tended to decrease with aging, but
there was no significant difference between 14-
week-old rats (G1) and 15-month-old rats (G3).
Among 15-month-old rats, the low- and high-
dose testosterone replacement rats showed a
significantly higher nitrite level per amount of
protein in the tissue and per tissue weight than
rats without replacement.  There was no signifi-
cant difference in nitrite levels between the
high- and the low-dose replacement rats (Table
2).
Nitrite/nitrate level
This level tended to decrease with
aging, but there was no significant dif-
ference between 14-week-old rats and
15-month-old rats without testosterone
replacement.  The nitrite/nitrate level
increased with testosterone replace-
ment; however, the difference was not
significant between 15-month-old rats
treated with and without testosterone
replacement (Table 2).
eNOS and nNOS immunohistochem-
istry in penile tissue
Figures 1 and 2 show light microscopic
photographs of the corpus cavernosum
from G1 to G5.  Immunohistochemical
localization of eNOS showed strong
staining of the vascular endothelium in
14-week-old rats (G1) (Fig. 1A).
Thirteen-month-old (G2) and 15-
month-old rats without testosterone re-
placement (G3) had weak staining
(Figs. 1B and C), and testosterone re-
placement restored the level of staining
(Figs. 1D and E).  Immunohistochemi-
cal stainings in 14-week-old rats, 15-
month-old rats with low- and high-dose
testosterone replacement rats were al-
most at the same level.  Immunohisto-
chemical staining with anti-nNOS
C: G3, middle-aged rat
D: G4, low-dose testosterone replaced
middle-aged rat
E: G5, high-dose testosterone replaced
middle-aged rat
            (G3–G5:  15-month-old)
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Fig. 2. Sections of rat corpus cavernosum tissue immunostained by ant-neuronal nitric oxide synthase
(nNOS) antibodies (original magnification × 200).
A, D and E: Nerve fibers are stained at the same level in G1, G4 and G5.
C: Staining is weaker than that of the young adult group.
[Figs. 2A and B on p. 50 and Figs. 2C–E on p. 51]
polyclonal antibody revealed the presence of
nNOS in the nerves.  The staining in 14-week-
old rats was strong (Fig. 2A), and the staining in
15-mon th -o ld  r a t s  w i th  t e s to s t e rone
replacement was almost the same in level as in
14-week-old rats (Figs. 2D and E).  In 15-
mon th -o ld  r a t s  w i thou t  t e s to s t e rone
replacement, nNOS was weakly positive (Fig.
2C).
Discussion
The results of this study using young adult and
middle-aged rats showed that there was an age-
related decrease in serum testosterone concen-
tration, NO level and NOS expression in the
corpus cavernosum, and moreover, that
in middle-aged rats with 2 months of
testosterone replacement which was
continued until the rats reached the age
of 15 months, those levels were
restored to the level in young adult rats.
Several reports show that a low
testosterone level decreases penile
erection and treatment with tes-
tosterone restores it (Mills et al., 1992;
Heaton and Varrin, 1994; Meisel and
Sachs, 1994; Garban et al., 1995).  One
important question is what is the role of
t e s t o s t e r on e  by  i t s e l f  i n  t h e
maintenance of penile erection.  The
author has significantly extended these
previous findings by demonstrating
that the most likely mechanism of
penile dysfunction is an aging-induced
reduction in the level of penile NO and
NOS, a reduction which is prevented
by testosterone.
A
B
Recently, several physiological studies
(Holmquist et al., 1991; Burnett et al., 1992) of
electrically induced erections as well as phar-
macological studies (Ignarro et al., 1990; Kim
et at, 1991; Rajifer et al., 1992) have indicated
that NO plays a major role in the mediation of
penile erection.  Penile erection results from
relaxation of the corporal smooth muscle and
penile cavernosal arteries.  NO mediates this
process as supported by evidence showing that
NO has a direct vasodilatory effect on caverno-
sal tissue and that relaxation of penile smooth
muscle is prevented by NOS inhibitors (Krane
et al., 1989; Seftel et al., 1994; Burnett, 1997).
The production of NO is mediated by a family
of NOS that all represent distinct gene products
(Forstermann et al., 1995).  There are 3 iso-
A: G1, young adult rat (14-week-old)
B: G2, middle-aged rat (13-month-old)
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1992).  The expression of eNOS protein and
mRNA has been examined in several disease
processes.  Increased expressions of eNOS
mRNA and protein has been found in athero-
sclerotic vessels and in response to shear stress
as well as estrogen (Kanazawa et al., 1992;
Nishida et al., 1992; Weiner et al., 1994).  In-
creased eNOS activity has been found in causes
of renal failure, whereas decreased
activity has been found in pulmonary
hypertension (Weiner et al., 1994;
Conger et al., 1995).  These suggest
that the eNOS expression is varied
and that its expression is a function
of the offending disease process.
eNOS has been thought to be a puta-
tive key enzyme of penile erection in
that acetylcholine stimulates the re-
lease of endothelium-derived relax-
ation factors from intact rabbit cavern-
osal smooth muscle cells (Seftel et
al., 1994) and also induces the relax-
ation of penile smooth muscle, a con-
dition which is reversed by NOS in-
hibitors (Kim et al., 1991).  Further-
more, impaired endothelium-depen-
dent corporal smooth muscle relaxa-
tion has been found in diabetic men
with erectile dysfunction (Saenz et
al., 1989).  The recent immunohisto-
chemical localization of eNOS in the
endothelial layers of the dorsal penile
arteries, veins and corporal sinusoids
places the enzyme in a physiolog-
ically critical location for mediating
penile erection (Burnett et al., 1996).
nNOS has been localized in the
rat penile autonomic nerves, the
adventitia of rat penile arterioles, and
the autonomic innervation of the
human penis (Burnett et al., 1993).  It
has also been reported that there are
C: G3, middle-aged rat
D: G4, low-dose testosterone replaced
middle-aged rat
E: G5, high-dose testosterone replaced
middle-aged rat
            (G3–G5:  15-month-old)
C
D
E
Figs. 2C–E.  Continued from the previous page.
forms, 2 constitutive and 1 inducible, which dif-
fer in their dependence on intracellular calcium.
Of the constitutive isoforms, eNOS was first
identified in bovine aortic endothelial cells and
appears to play an important role in the trans-
duction of signals from the bloodstream to the
underlying smooth muscle which causes vaso-
relaxation (Lamas et al., 1992; Sessa et al.,
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numerous NOS-containing nerve fibers and
terminals innervating corpus cavernosum
smooth muscles and vessels in the spaces of the
corpus cavernosum.
The presumed role of nNOS in penile erec-
tion has been studied in rats by using electrical
stimulation of the pelvic nerves, which caused
penile erection that was prevented by the NOS
inhibitor L-nitroarginine methyl ester (Burnett
et al., 1992, 1996; Bush et al., 1992).  The NOS
activity (presumed to be nNOS) has been indi-
rectly measured in penile tissue homogenates
by using a [3H]-L-arginine to [3H]-citrulline
conversion assay, which, along with Western
blotting analysis, showed a decrease in penile
NOS activity and penile nNOS protein content
in diabetic rats with erectile dysfunction
(Vernet et al., 1995).  A recent demonstration
that nNOS-deficient transgenic mice maintain a
normal penile erection throughout eNOS-
dependent production of NO suggests that
eNOS may also have an important primary and
compensatory role in mediating penile erection
(Burnett et al., 1996).
Previous studies have shown a decreased
penile NOS activity in models of erectile dys-
function, such as hypogonadism, androgen re-
ceptor blockade and diabetes (Burnett et al.,
1992).  Our model of middle-aged rats had a
low level of the penile NOS expression.  Lugg
et al. (1995) reported that in rats, aging induced
a considerable reduction in the erectile response
to electric field stimulation which was accom-
panied by a decrease in NOS activity in very old
rats.  Several reports have shown that a low tes-
tosterone level decreases penile erection and
testosterone restores it (Mills et al., 1992; Heaton
and Varrin 1994; Meisel and Sachs, 1994; Garban
et al., 1995).
The results of this study showed that total
and free testosterone levels tended to decrease
with aging, simultaneously with the penile NO
concentration and NOS expression.  Testoster-
one replacement restored these levels.  As men-
tioned above, testosterone may play a major
role in the mediation of penile erection by af-
fecting the pathway relaxing the corpus caver-
nosum smooth muscle in a manner that is de-
pendent on the NOS activity.  It is believed that
testosterone replacement might be an effective
method of treating erectile dysfunction that
occurs with aging.
In summary, the serum testosterone concen-
tration, penile NO concentration and NOS ex-
pression decreased with aging and were restor-
ed by testosterone replacement.  According to
the literature, NO plays a major role in the med-
iation of penile erection, and the present results
suggest that testosterone replacement might be
an effective method of treating erectile dysfunc-
tion that occurs with aging.
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